Pinhole Optics Meet Cataract Surgery - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Pinhole Optics Meet Cataract Surgery

Small-aperture IOL shows promise for cataract patients with pre-existing corneal comorbidities

  • July 28, 2026

  • 3 min

Share

Objective:

To evaluate the outcomes of the IC-8 pinhole intraocular lens (IOL) in patients with cataract and significant corneal comorbidities.

Approach:
  • Study Design: Retrospective review of 67 eyes from 45 patients who underwent IC-8 IOL implantation.
  • Patient Demographics: Included patients with keratoconus, previous corneal transplantation, radial keratotomy, corneal scarring, and herpetic keratopathy.
  • IOL Design: The IC-8 lens features a 1.36 mm central aperture to reduce optical aberrations.
Key Findings:
  • Mean corrected distance visual acuity improved from 0.56 logMAR preoperatively to 0.16 logMAR postoperatively.
  • 61.1% of eyes achieved 6/9 vision or better; 75.9% reached 6/12 vision or better.
  • Mean postoperative spherical equivalent refraction was −0.17 D, with over 50% of eyes within 0.50 D of target.
  • Nearly 70% of keratoconic eyes achieved uncorrected visual acuity of 6/9 or better.
Interpretation:

Limitations:
  • Retrospective study design may limit the strength of conclusions.
  • Outcomes varied based on specific corneal conditions, with less favorable results in corneal scarring or herpetic disease.
Conclusion:

Sources:

Original Source(s)

Pinhole Optics Meet Cataract Surgery

  • July 28, 2026

Related Content

Chinese Trial Validates Scleral Lenses

Large Chinese trial confirms strong visual outcomes with four-zone scleral lenses for irregular corneas

  • August 28, 2026

  • 3 min
Vitrectomy Linked to Higher CME Risk

Large US database study suggests previous pars plana vitrectomy may substantially increase likelihood of pseudophakic cystoid macular edema

  • August 26, 2026

  • 3 min
The Gut–Eye Cataract Connection

Multiomics study reveals reduced anti-inflammatory gut metabolites and altered bacterial populations in patients with age-related cataract

  • July 9, 2026

  • 3 min